71 related articles for article (PubMed ID: 20970029)
1. Localized low-dose radiotherapy for follicular lymphoma: history, clinical results, mechanisms of action, and future outlooks.
Ganem G; Cartron G; Girinsky T; Haas RL; Cosset JM; Solal-Celigny P
Int J Radiat Oncol Biol Phys; 2010 Nov; 78(4):975-82. PubMed ID: 20970029
[TBL] [Abstract][Full Text] [Related]
2.
Frank MJ; Reagan PM; Bartlett NL; Gordon LI; Friedberg JW; Czerwinski DK; Long SR; Hoppe RT; Janssen R; Candia AF; Coffman RL; Levy R
Cancer Discov; 2018 Oct; 8(10):1258-1269. PubMed ID: 30154192
[TBL] [Abstract][Full Text] [Related]
3. Low-dose radiotherapy of osteoarthritis: from biological findings to clinical effects-challenges for future studies.
Weissmann T; Rückert M; Putz F; Donaubauer AJ; Hecht M; Schnellhardt S; Schubert P; Roesch J; Höfler D; Ott OJ; Haderlein M; Lettmaier S; Fietkau R; Frey B; Gaipl US; Deloch L
Strahlenther Onkol; 2023 Dec; 199(12):1164-1172. PubMed ID: 36602569
[TBL] [Abstract][Full Text] [Related]
4. Low-dose radiation therapy (LDRT) for COVID-19 and its deadlier variants.
Kapoor R; Welsh JS; Dhawan V; Javadinia SA; Calabrese EJ; Dhawan G
Arch Toxicol; 2021 Oct; 95(10):3425-3432. PubMed ID: 34302492
[TBL] [Abstract][Full Text] [Related]
5. Low-dose radiation therapy mobilizes antitumor immunity: New findings and future perspectives.
Zhou L; Liu Y; Wu Y; Yang X; Spring Kong FM; Lu Y; Xue J
Int J Cancer; 2024 Apr; 154(7):1143-1157. PubMed ID: 38059788
[TBL] [Abstract][Full Text] [Related]
6. Radiotherapy of follicular lymphoma: updated role and new rules.
Yahalom J
Curr Treat Options Oncol; 2014 Jun; 15(2):262-8. PubMed ID: 24700284
[TBL] [Abstract][Full Text] [Related]
7. 4 Gy versus 24 Gy radiotherapy for patients with indolent lymphoma (FORT): a randomised phase 3 non-inferiority trial.
Hoskin PJ; Kirkwood AA; Popova B; Smith P; Robinson M; Gallop-Evans E; Coltart S; Illidge T; Madhavan K; Brammer C; Diez P; Jack A; Syndikus I
Lancet Oncol; 2014 Apr; 15(4):457-63. PubMed ID: 24572077
[TBL] [Abstract][Full Text] [Related]
8. Modern radiation therapy for nodal non-Hodgkin lymphoma-target definition and dose guidelines from the International Lymphoma Radiation Oncology Group.
Illidge T; Specht L; Yahalom J; Aleman B; Berthelsen AK; Constine L; Dabaja B; Dharmarajan K; Ng A; Ricardi U; Wirth A;
Int J Radiat Oncol Biol Phys; 2014 May; 89(1):49-58. PubMed ID: 24725689
[TBL] [Abstract][Full Text] [Related]
9. Excellent response to very-low-dose radiation (4 Gy) for indolent B-cell lymphomas: is 4 Gy suitable for curable patients?
Imber BS; Chau KW; Lee J; Lee J; Casey DL; Yang JC; Wijentunga NA; Shepherd A; Hajj C; Qi S; Chelius MR; Hamlin PA; Palomba ML; Joffe E; Zhang Z; Zelenetz AD; Salles GA; Yahalom J
Blood Adv; 2021 Oct; 5(20):4185-4197. PubMed ID: 34529789
[TBL] [Abstract][Full Text] [Related]
10. Repeated courses of low-dose 2 × 2 Gy radiation therapy in patients with indolent B-cell non-Hodgkin lymphomas.
Saleh K; Michot JM; Schernberg A; Lazarovici J; Chahine C; Danu A; Khalife-Saleh N; Rossignol J; Ghez D; Martin V; Mazeron R; Fermé C; Boros A; Ribrag V; Girinsky T
Cancer Med; 2020 Jun; 9(11):3725-3732. PubMed ID: 32249547
[TBL] [Abstract][Full Text] [Related]
11. Therapy of nodal Follicular Lymphoma (WHO grade 1/2) in clinical stage I/II using response adapted Involved Site Radiotherapy in combination with Obinutuzumab (Gazyvaro) - GAZAI Trial (GAZyvaro and response adapted Involved-site Radiotherapy): a study protocol for a single-arm, non-randomized, open, national, multi-center phase II trial.
König L; Dreyling M; Dürig J; Engelhard M; Hohloch K; Viardot A; Witzens-Harig M; Kieser M; Klapper W; Pott C; Herfarth K
Trials; 2019 Aug; 20(1):544. PubMed ID: 31470902
[TBL] [Abstract][Full Text] [Related]
12. Irradiation Enhances Abscopal Anti-tumor Effects of Antigen-Specific Immunotherapy through Regulating Tumor Microenvironment.
Chang MC; Chen YL; Lin HW; Chiang YC; Chang CF; Hsieh SF; Chen CA; Sun WZ; Cheng WF
Mol Ther; 2018 Feb; 26(2):404-419. PubMed ID: 29248428
[TBL] [Abstract][Full Text] [Related]
13. Limited Stage Follicular Lymphoma: Current Role of Radiation Therapy.
Filippi AR; Ciammella P; Ricardi U
Mediterr J Hematol Infect Dis; 2016; 8(1):e2016041. PubMed ID: 27648204
[TBL] [Abstract][Full Text] [Related]
14. Radiotherapy of indolent orbital lymphomas : Two radiation concepts.
König L; Stade R; Rieber J; Debus J; Herfarth K
Strahlenther Onkol; 2016 Jun; 192(6):414-21. PubMed ID: 27160291
[TBL] [Abstract][Full Text] [Related]
15. Does Radiation Have a Role in Advanced Stage Hodgkin's or Non-Hodgkin Lymphoma?
Specht L
Curr Treat Options Oncol; 2016 Jan; 17(1):4. PubMed ID: 26739151
[TBL] [Abstract][Full Text] [Related]
16. USP9X inhibition promotes radiation-induced apoptosis in non-small cell lung cancer cells expressing mid-to-high MCL1.
Kushwaha D; O'Leary C; Cron KR; Deraska P; Zhu K; D'Andrea AD; Kozono D
Cancer Biol Ther; 2015; 16(3):392-401. PubMed ID: 25692226
[TBL] [Abstract][Full Text] [Related]
17. Complement-dependent modulation of antitumor immunity following radiation therapy.
Elvington M; Scheiber M; Yang X; Lyons K; Jacqmin D; Wadsworth C; Marshall D; Vanek K; Tomlinson S
Cell Rep; 2014 Aug; 8(3):818-30. PubMed ID: 25066124
[TBL] [Abstract][Full Text] [Related]
18. Rapid decline of follicular lymphoma-associated chylothorax after low dose radiotherapy to retroperitoneal lymphoma localization.
Van De Voorde L; Vanneste B; Borger J; Troost EG; Werner P
Case Rep Hematol; 2014; 2014():684689. PubMed ID: 24891961
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
